Patrice Matchaba, M.D., has been Group Head of Global Health & Corporate Responsibility for Novartis since October 2017.

Dr. Matchaba most recently served as Global Head of the Cardio-Metabolic development unit at Novartis, where he led the global clinical development of the cardio-metabolic portfolio. He joined Novartis South Africa in 2000 as the Country Pharma Organization Chief Scientific Officer. Since moving to Novartis Pharmaceuticals Corporation in the United States in 2002, he has held several roles of increasing responsibility, such as Therapeutic Area Head for Immunology and Infectious Diseases; Global Head of Drug Safety and Epidemiology; and Global Head of the Integrated Development Functions and Regions, which include Global Clinical Operations, Global Clinical Submissions, Integrated Information Sciences, Development Informatics, Development Diversity and Inclusion, and all Medical Country Pharma Organization regions.

Dr. Matchaba completed his medical training at the University of Zimbabwe, and is a fellow of the College of Obstetrics and Gynecology South Africa. In addition, he is a graduate of Harvard Business School’s Program for Management Development.